Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells

Go back to Autolus Therapeutics announces publication describing its small molecule-regulated CAR T cells
(NASDAQ: AUTL) Delayed: 1.93 +0.01 (0.52%)
Previous Close $1.92    52 Week High
Open $1.92    52 Week Low
Day High $1.94    P/E N/A 
Day Low $1.88    EPS
Volume 626,820